{"ticker": {"uuid": "9a2645b9-8df9-4000-aef7-d37be6cdce73", "symbol": "6990", "name": "Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.", "exchange": "HKG", "country": "HK", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Sichuan Kelun-Biotech Seeks HK$2.7 Billion via Share Placement", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxPYVRRckRBVnlNdmJVUlo3N1pfdk5KUnlqaUYxd3RvOHByN2dpZGJqazJRblQ0ZnFMTUltMzJnZ1Z3SXdMQ3B6ZEFKYnJqQ3haaFF2VUt6SHoxOHNEX2p3azROQVEyZU5ZR2lNWWI1TmtwVVdEd254VnFNNE15cjhPSXhIZE1KOThKN1RweFpnSExjRThqRDFsZWFNczVZa3QxNWdOOHZCd3lzUjRCN2wtcXZyYVJ2dw?oc=5", "source_name": "marketscreener.com", "published_at": "2026-07-08T02:34:21+00:00", "published_display": "08 Jul 2026 02:34", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Sichuan Kelun Biotech Biopharmaceutical (SEHK:6990) Cheap On New Cancer Cell Research?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-02T07:00:00+00:00", "published_display": "02 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sichuan Kelun-Biotech Biopharmaceutical (SEHK:6990) Is Down 14.8% After ASCO NSCLC Data Spotlight - Has The Bull Case Changed?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-06T07:00:00+00:00", "published_display": "06 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Sichuan Kelun-Biotech (SEHK:6990) Is Down 8.2% After ASCO Lung Cancer Data Upside Surprise And What's Next", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxNZ2tQbXdYOXk1REZHZXBxNk0wd2Q0aU1MdlhNQnNULWpvUzgtX0FhRTdNaV9Ibld5M2g3T2VUTjZmRDZraFdqYlMyWEVOamdDTF9BTUFzcDlGMVhRXzFHU2lYYWtOd1dHc09ISTZEeXRKMWs3VHlNN1lxZmpwUTBBS1hxYkdSNWVJcDhZT3YwZkppVzZMSmU5MFVQNTlZUzM4?oc=5", "source_name": "Market source", "published_at": "2026-06-01T07:00:00+00:00", "published_display": "01 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is It Time To Reassess Sichuan Kelun-Biotech Biopharmaceutical (SEHK:6990) After Recent Share Price Weakness?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-03-24T07:00:00+00:00", "published_display": "24 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Sichuan Kelun-Biotech Seeks HK$2.7 Billion via Share Placement", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxPYVRRckRBVnlNdmJVUlo3N1pfdk5KUnlqaUYxd3RvOHByN2dpZGJqazJRblQ0ZnFMTUltMzJnZ1Z3SXdMQ3B6ZEFKYnJqQ3haaFF2VUt6SHoxOHNEX2p3azROQVEyZU5ZR2lNWWI1TmtwVVdEd254VnFNNE15cjhPSXhIZE1KOThKN1RweFpnSExjRThqRDFsZWFNczVZa3QxNWdOOHZCd3lzUjRCN2wtcXZyYVJ2dw?oc=5", "source_name": "marketscreener.com", "published_at": "2026-07-08T02:34:21+00:00", "published_display": "08 Jul 2026 02:34", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Sichuan Kelun Biotech Biopharmaceutical (SEHK:6990) Cheap On New Cancer Cell Research?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-02T07:00:00+00:00", "published_display": "02 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sichuan Kelun-Biotech Biopharmaceutical (SEHK:6990) Is Down 14.8% After ASCO NSCLC Data Spotlight - Has The Bull Case Changed?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-06T07:00:00+00:00", "published_display": "06 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Sichuan Kelun-Biotech (SEHK:6990) Is Down 8.2% After ASCO Lung Cancer Data Upside Surprise And What's Next", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxNZ2tQbXdYOXk1REZHZXBxNk0wd2Q0aU1MdlhNQnNULWpvUzgtX0FhRTdNaV9Ibld5M2g3T2VUTjZmRDZraFdqYlMyWEVOamdDTF9BTUFzcDlGMVhRXzFHU2lYYWtOd1dHc09ISTZEeXRKMWs3VHlNN1lxZmpwUTBBS1hxYkdSNWVJcDhZT3YwZkppVzZMSmU5MFVQNTlZUzM4?oc=5", "source_name": "Market source", "published_at": "2026-06-01T07:00:00+00:00", "published_display": "01 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is It Time To Reassess Sichuan Kelun-Biotech Biopharmaceutical (SEHK:6990) After Recent Share Price Weakness?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-03-24T07:00:00+00:00", "published_display": "24 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 82, "total_relevant": 5, "sentiment_summary": {"positive": 1, "negative": 0, "neutral": 4, "score": 53, "total": 5, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 82, "events": [{"event": "general", "label": "Market update", "weight": 2.75, "count": 5}], "positive_events": 1, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 516.5, "latest_week": "2026-07-10", "one_week_move": 3.5, "four_week_move": 24.4, "twelve_week_move": -0.7, "trend_signal": "1", "trend_label": "Trend active", "trend_tone": "positive", "market_dynamics": 0.009907, "market_dynamics_buy_signal": false, "relative_strength": 22.437928, "fair_value_gap": 97.0, "fair_value_label": "Materially above fair value", "fair_value_tone": "negative", "expectation_direction": "undecided", "expectation_probability": 51.95, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+3.5% over one week, +24.4% over four weeks, trend active, and materially above fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 62, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "simplywall.st", "count": 3}, {"label": "marketscreener.com", "count": 1}, {"label": "Market source", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 5}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 5}]}, "insights": [{"label": "Weighted tone", "value": "53/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "82/100 classification confidence."}, {"label": "Company focus", "value": "5", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend active", "tone": "positive", "text": "+3.5% over one week, +24.4% over four weeks, trend active, and materially above fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Sichuan Kelun-Biotech Seeks HK$2.7 Billion via Share Placement"}], "updated_at": "2026-07-17T20:08:42.125987+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}